RIMFROST AS is a Norwegian biotech company, specializing in the production of krill-derived products. With a dedication to sustainability, the organization has established itself as a key player in the nutritional sector, emphasizing the development of innovative krill-derived omega-3 products for human, feed, and animal health. The strength of krill lies in its high concentrations of efficient omega-3 fatty acids bound in phospholipids, high-quality marine proteins, and the powerful antioxidant astaxanthin. RIMFROST AS is committed to preserving the Antarctic ecosystem, adhering to strict regulations and controls, and ensuring high-quality krill products through gentle processing and minimal environmental impact. One of RIMFROST's key differentiators is its 100% ownership of the short value chain, which ensures precise quality and reliable production capacity, offering traceability at every step. The company has also been certified by the Marine Stewardship Council (MSC) and Friend of the Sea, underscoring its commitment to sustainability and adherence to industry standards. Founded in 2001, RIMFROST AS operates in the industries of Manufacturing, Nutrition, and Sustainability, demonstrating its comprehensive approach to the production and promotion of krill-derived products. The company's specific headquarters location and details concerning its last investment and investors are not provided at this time.
There is no investment information
No recent news or press coverage available for RIMFROST AS.